title: Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
authors.affiliation: Institute for Pathology, University Hospital Basel, Basel, Switzerland. izlobec@uhbs.ch
authors.forename: Inti
authors.initials: I
authors.lastname: Zlobec
authors.forename: Francesca
authors.initials: F
authors.lastname: Molinari
authors.forename: Vittoria
authors.initials: V
authors.lastname: Martin
authors.forename: Luca
authors.initials: L
authors.lastname: Mazzucchelli
authors.forename: Piercarlo
authors.initials: P
authors.lastname: Saletti
authors.forename: Rosangela
authors.initials: R
authors.lastname: Trezzi
authors.forename: Sara
authors.initials: S
authors.lastname: De Dosso
authors.forename: Tatjana
authors.initials: T
authors.lastname: Vlajnic
authors.forename: Milo
authors.initials: M
authors.lastname: Frattini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Lugli